KW CFO Enbody reports performance share vesting

Kennedy-Wilson Holdings, Inc. Chief Financial Officer Justin Enbody reported equity compensation activity involving the company’s common stock.

Rhea-AI Filing Summary

Kennedy-Wilson Holdings, Inc. Chief Financial Officer Justin Enbody reported equity compensation activity involving the company’s common stock. On February 25, 2026, he acquired three blocks of shares by grant or award totaling 16,584, 26,265 and 39,113 shares at a price of $0.0000 per share. After these transactions, his direct holdings rose through successive steps to 933,909 common shares.

Footnotes explain these awards relate to performance-based restricted shares under the equity plan that vest only if specified performance hurdles are met. On that date, hurdles were achieved for awards totaling 33,762, 53,472 and 79,628 shares, with 17,178, 27,207 and 40,515 shares, respectively, withheld by the company to cover tax obligations.

Insider Trade Summary

Grant/Award: 81,962 shares

Grant/Award 3 txns

Insider Enbody Justin

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	16,584	$0.00	$0.00
Grant/Award	Common Stock	26,265	$0.00	$0.00
Grant/Award	Common Stock	39,113	$0.00	$0.00

Holdings After Transaction: Common Stock — 933,909 shares (Direct)

Footnotes (3)

1. F1. The reporting person was previously granted performance-based restricted shares pursuant to the equity plan that vest if the registrant satisfies certain performance hurdles. On February 25, 2026, the performance hurdles were satisfied at levels which resulted in the vesting of a total of 33,762 shares, of which 17,178 shares were withheld by the registrant to satisfy tax withholding obligations.
2. F2. The reporting person was previously granted performance-based restricted shares pursuant to the equity plan that vest if the registrant satisfies certain performance hurdles. On February 25, 2026, the performance hurdles were satisfied at levels which resulted in the vesting of a total of 53,472 shares, of which 27,207 shares were withheld by the registrant to satisfy tax withholding obligations.
3. F3. The reporting person was previously granted performance-based restricted shares pursuant to the equity plan that vest if the registrant satisfies certain performance hurdles. On February 25, 2026, the performance hurdles were satisfied at levels which resulted in the vesting of a total of 79,628 shares, of which 40,515 shares were withheld by the registrant to satisfy tax withholding obligations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did KW CFO Justin Enbody report on this Form 4?

Justin Enbody reported equity grants in Kennedy-Wilson common stock. On February 25, 2026, he acquired three tranches of 16,584, 26,265 and 39,113 shares via grants or awards at zero cost, increasing his directly held shares to 933,909.

Were Justin Enbody’s KW stock transactions open-market buys or equity awards?

They were equity awards, not open-market purchases. Each transaction is coded “A” for grant, award, or other acquisition, with a reported price of $0.0000 per share, indicating stock issued as compensation under an equity plan, rather than bought in the market.

How many Kennedy-Wilson shares does Justin Enbody hold after these Form 4 grants?

Following the reported equity awards, Justin Enbody’s direct ownership increased over three steps, ending at 933,909 common shares. Each acquisition raised his holdings from 868,531 to 894,796 and then to 933,909 shares, all reported as directly owned.

What performance conditions were tied to Justin Enbody’s KW restricted share vesting?

The restricted shares were performance-based, vesting only if Kennedy-Wilson met specified performance hurdles. On February 25, 2026, those hurdles were achieved for multiple grants, triggering vesting of 33,762, 53,472 and 79,628 shares under the company’s equity plan.

Why were some of Justin Enbody’s vested KW shares withheld by the company?

A portion of the vested performance-based restricted shares was withheld to satisfy tax withholding obligations. For the three vestings, Kennedy-Wilson retained 17,178, 27,207 and 40,515 shares, respectively, while the balance of each grant was delivered to Enbody.

Does this KW Form 4 show any stock sales by Justin Enbody?

No stock sales are reported. All three transactions are coded as “A” for grant, award, or other acquisition of common stock. The only share reductions noted in footnotes reflect company tax withholding on vested performance-based restricted share awards, not open-market sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 06:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Enbody Justin

(Last) (First) (Middle)

C/O 151 S. EL CAMINO DRIVE

(Street)

BEVERLY HILLS CA 90212

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kennedy-Wilson Holdings, Inc. [ KW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		A		16,584(1)	A	$0	868,531	D
Common Stock	02/25/2026		A		26,265(2)	A	$0	894,796	D
Common Stock	02/25/2026		A		39,113(3)	A	$0	933,909	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person was previously granted performance-based restricted shares pursuant to the equity plan that vest if the registrant satisfies certain performance hurdles. On February 25, 2026, the performance hurdles were satisfied at levels which resulted in the vesting of a total of 33,762 shares, of which 17,178 shares were withheld by the registrant to satisfy tax withholding obligations.

2. The reporting person was previously granted performance-based restricted shares pursuant to the equity plan that vest if the registrant satisfies certain performance hurdles. On February 25, 2026, the performance hurdles were satisfied at levels which resulted in the vesting of a total of 53,472 shares, of which 27,207 shares were withheld by the registrant to satisfy tax withholding obligations.

3. The reporting person was previously granted performance-based restricted shares pursuant to the equity plan that vest if the registrant satisfies certain performance hurdles. On February 25, 2026, the performance hurdles were satisfied at levels which resulted in the vesting of a total of 79,628 shares, of which 40,515 shares were withheld by the registrant to satisfy tax withholding obligations.

Remarks:

	/s/ Justin Enbody	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.